IDENTIFICATION OF RAS FARNESYLTRANSFERASE INHIBITORS BY MICROBIAL SCREENING

被引:254
作者
HARA, M
AKASAKA, K
AKINAGA, S
OKABE, M
NAKANO, H
GOMEZ, R
WOOD, D
UH, M
TAMANOI, F
机构
[1] KYOWA HAKKO KOGYO CO LTD,TOKYO RES LABS,ASAHI MACHI 3-6-6,MACHIDA,TOKYO 194,JAPAN
[2] KYOWA HAKKO KOGYO CO LTD,PHARMACEUT RES LABS,MACHIDA,TOKYO 194,JAPAN
[3] UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637
关键词
GPAL MUTANT; MANUMYCIN; COMPETITIVE INHIBITION; ANTITUMOR ACTIVITY;
D O I
10.1073/pnas.90.6.2281
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A microbial screen using a yeast strain with conditional deficiency in the GPA1 gene was carried out to search for inhibitors of protein farnesyltransferase (PFT). A strain of Streptomyces was found to produce active compounds named UCF1-A, UCF1-B, and UCF1-C. Structural determination of these compounds revealed that UCF1-C is identical to the known antibiotic, manumycin, whereas UCF1-A and UCF1-B are structurally related to manumycin. All three UCF1 compounds suppress the lethality of gpa1 disruption, with UCF1-C exhibiting the strongest activity. UCF1 inhibits yeast as well as rat brain PFT. Fifty percent inhibition of yeast PFT activity is observed with 5 muM UCF1-C. Kinetic analyses of the inhibition suggest that UCF1-C acts as a competitive inhibitor of PFT with respect to farnesyl pyrophosphate, exhibiting a K(i) of 1.2 muM, whereas the same compound appears to act as a noncompetitive inhibitor of PFT with respect to the farnesyl acceptor, the Ras protein. UCF1-C shows significant activity to inhibit the growth of Ki-ras-transformed fibrosarcoma, raising the possibility of its use as an antitumor drug.
引用
收藏
页码:2281 / 2285
页数:5
相关论文
共 33 条
[1]  
AKINAGA S, 1991, CANCER RES, V51, P4888
[2]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[3]  
BUZZETTI F, 1963, PHARM ACTA HELV, V38, P871
[4]   CDNA CLONING AND EXPRESSION OF THE PEPTIDE-BINDING BETA-SUBUNIT OF RAT P21RAS FARNESYLTRANSFERASE, THE COUNTERPART OF YEAST DPR1/RAM1 [J].
CHEN, WJ ;
ANDRES, DA ;
GOLDSTEIN, JL ;
RUSSELL, DW ;
BROWN, MS .
CELL, 1991, 66 (02) :327-334
[5]   INHIBITION OF FARNESYL TRANSFERASES FROM MALIGNANT AND NONMALIGNANT CULTURED HUMAN-LYMPHOCYTES BY PRENYL SUBSTRATE-ANALOGS [J].
DAS, NP ;
ALLEN, CM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (02) :729-735
[6]  
DER CJ, 1991, CANCER CELL-MON REV, V3, P331
[7]   COMMON MODIFICATIONS OF TRIMERIC-G PROTEINS AND RAS PROTEIN - INVOLVEMENT OF POLYISOPRENYLATION [J].
FINEGOLD, AA ;
SCHAFER, WR ;
RINE, J ;
WHITEWAY, M ;
TAMANOI, F .
SCIENCE, 1990, 249 (4965) :165-169
[8]   PROTEIN GERANYLGERANYLTRANSFERASE OF SACCHAROMYCES-CEREVISIAE IS SPECIFIC FOR CYS-XAA-XAA-LEU MOTIF PROTEINS AND REQUIRES THE CDC43 GENE-PRODUCT BUT NOT THE DPR1 GENE-PRODUCT [J].
FINEGOLD, AA ;
JOHNSON, DI ;
FARNSWORTH, CC ;
GELB, MH ;
JUDD, SR ;
GLOMSET, JA ;
TAMANOI, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4448-4452
[9]  
GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1
[10]   RAS C-TERMINAL PROCESSING ENZYMES - MINIREVIEW NEW DRUG TARGETS [J].
GIBBS, JB .
CELL, 1991, 65 (01) :1-4